BITS Pilani Institutional Repository: Browsing DSpace

Browsing by Author Murugesan, Sankaranarayanan

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 12 to 31 of 59 < previous next >

Issue Date	Title	Author(s)
2021-09	Design, synthesis and evaluation of novel β-carboline ester analogues as potential anti-leishmanial agents	Murugesan, Sankaranarayanan
2022-01	Design, synthesis and structure–activity relationship studies of novel spirochromanone hydrochloride analogs as anticancer agents	Murugesan, Sankaranarayanan
2023-01	Design, synthesis, anti-acetylcholinesterase evaluation and molecular modelling studies of novel coumarin-chalcone hybrids	Murugesan, Sankaranarayanan
2020-07	Design, synthesis, in silico studies, and evaluation of novel chalcones and their pyrazoline derivatives for antibacterial and antitubercular activities	Murugesan, Sankaranarayanan
2020-05	Design, synthesis, α-amylase inhibition and in silico docking study of novel quinoline bearing proline derivatives	Murugesan, Sankaranarayanan
2020-07	Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents	Murugesan, Sankaranarayanan
2023-07	Discovery of Novel Coumarin-Schiff Base Hybrids as Potential Acetylcholinesterase Inhibitors: Design, Synthesis, Enzyme Inhibition, and Computational Studies	Murugesan, Sankaranarayanan
2023-04	Discovery of potent DNMT1 inhibitors against sickle cell disease using structural-based virtual screening, MM-GBSA and molecular dynamics simulation-based approaches	Murugesan, Sankaranarayanan
2020-11	Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19	Murugesan, Sankaranarayanan
2020-02	Formulation and characterization of folate receptor-targeted PEGylated liposome encapsulating bioactive compounds from Kappaphycus alvarezii for cancer therapy	Murugesan, Sankaranarayanan
2023-04	Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates	Murugesan, Sankaranarayanan
2022	Graph theoretical network analysis, in silico exploration, and validation of bioactive compounds from Cynodon dactylon as potential neuroprotective agents against α-synuclein	Murugesan, Sankaranarayanan
2019	Green Synthesis, in-vitro Antimicrobial Evaluation, Docking, and SAR Studies of Potent Quinoline-4-Carboxylic Acids	Jha, Prabhat N.; Murugesan, Sankaranarayanan; Shukla, Paritosh
2022-12	Identification of Papain-Like Protease inhibitors of SARS CoV-2 through HTVS, Molecular docking, MMGBSA and Molecular dynamics approach	Murugesan, Sankaranarayanan
2022-08	In silico and in vitro analysis of PPAR – α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat	Murugesan, Sankaranarayanan
2023-07	In silico anti-viral assessment of phytoconstituents in a traditional (Siddha Medicine) polyherbal formulation – Targeting Mpro and pan-coronavirus post-fusion Spike protein	Murugesan, Sankaranarayanan
2023-11	In Silico Exploration of Bisphosphonate Scaffolds as Potential Inhibitors of SARS-CoV-2 RdRp for COVID-19 and PASC	Murugesan, Sankaranarayanan
2020-10	In-vivo and in-silico toxicity studies of daidzein: an isoflavone from soy	Murugesan, Sankaranarayanan
2020	Leishmaniasis is the most widespread pathogenic disease in several countries. Currently, no effective vaccines are available, and the control of Leishmaniasis primarily relies on decade-old chemotherapy. The treatment for the Leishmaniasis is not up to the mark. Current therapy for Leishmaniasis is ancient and requires hospitalization for the administration. These medications are also highly toxic and resistant. β-carboline, a natural indole containing alkaloid, holds a vital position in the field of medicinal chemistry with a diversified pharmacological action. The current review focuses mainly on the anti-leishmanial effects of β-carboline analogs and their synthetic strategies, structural activity relationship studies (SAR). The past ten years alterations unveiled by β-carboline analogs present in phytoconstituents and various derivatives of synthesized analogs with the mechanism of action were briefly shortlisted and illustrated	Murugesan, Sankaranarayanan
2022-06	Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases	Murugesan, Sankaranarayanan

Showing results 12 to 31 of 59 < previous next >